Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome | Zendy

Andrea J. Cussons | Zendy; Gerald F. Watts | Zendy; V. Burke | Zendy; Jonathan E. Shaw | Zendy; Paul Zimmet | Zendy; Bronwyn Stuckey | Zendy

Open Access

Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome

Author(s) -

Andrea J. Cussons,

Gerald F. Watts,

V. Burke,

Jonathan E. Shaw,

Paul Zimmet,

Bronwyn Stuckey

Publication year - 2008

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/den263

Subject(s) - polycystic ovary , metabolic syndrome , medicine , ovary , gynecology , endocrinology , physiology , insulin resistance , obesity

Polycystic ovary syndrome (PCOS) is associated with insulin resistance and features in common with the metabolic syndrome (MetS)--factors shown to predict cardiovascular risk and type 2 diabetes. We investigated the prevalence and characteristics of the MetS in PCOS by three definitions-World Health Organization (WHO), National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP-III) and International Diabetes Federation (IDF)--and compared that with the background population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research